NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Alibaba
BABA
US Stock MarketDetailed Quotes
GALT Galectin Therapeutics
- 1.470
- +0.010+0.68%
Close Feb 25 16:00 ET
- 1.422
- -0.048-3.27%
Pre 08:15 ET
92.26MMarket Cap-2.01P/E (TTM)
1.490High1.425Low158.51KVolume1.460Open1.460Pre Close231.61KTurnover0.36%Turnover RatioLossP/E (Static)62.76MShares4.26852wk High-0.97P/B64.54MFloat Cap0.72652wk Low--Dividend TTM43.90MShs Float38.280Historical High--Div YieldTTM4.45%Amplitude0.300Historical Low1.461Avg Price1Lot Size
Galectin Therapeutics News
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Shlevin Harold H.
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Uihlein Richard E
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Zordani Richard A. Jr.
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director OMENN GILBERT S
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rubin Marc
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Schwartz Elissa J.
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEWIS JOEL
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jamil Khurram
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FREEMAN KEVIN D
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer CALLICUTT JACK W
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CARSON BENJAMIN SR
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ELDRED KARY
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director OMENN GILBERT S
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Shlevin Harold H.
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jamil Khurram
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEWIS JOEL
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer CALLICUTT JACK W
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Zordani Richard A. Jr.
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ELDRED KARY
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FREEMAN KEVIN D